Finbiosoft

Espoo, Finland Founded: 2011 • Age: 15 yrs Acquired By BYG4lab
Cloud-based software for laboratory method and instrument verifications

About Finbiosoft

Finbiosoft is a Healthcare company based in Espoo (Finland) founded in 2011 by Teemu Qvick, Jani Huttunen, and Akseli Virtanen, and was acquired by BYG4lab in March 2024. Its chief executive, as recorded, is Akseli Virtanen. Finbiosoft offers products and services including Validation Manager, EQA Manager, and Results Manager. Its focus areas include HealthTech, Healthcare IT, Provider and Hospital Information Systems. Its legal entity is Finbiosoft Oy.

Company details

Cloud-based software for laboratory method and instrument verifications. The companys software suite includes Validation Manager, EQA Manager, and Results Manager for instrument and assay verifications and validations.

  • Headquarters Espoo, Finland
  • Founders Teemu Qvick, Jani Huttunen, Akseli Virtanen
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website finbiosoft.com
  • Social LinkedIn X Facebook YouTube
  • Acquired by BYG4lab (Mar 2024)
  • Legal Name Finbiosoft Oy
Key Metrics

Products & Services of Finbiosoft

Finbiosoft offers a comprehensive portfolio of products and services, including Validation Manager, EQA Manager, and Results Manager.

Validation Manager
Verification Software

Automates verifications of diagnostics methods and instruments for labs.

EQA Manager
EQA Management

Simplifies management of EQA rounds and proficiency testing processes.

Results Manager
Result Analysis

Accelerates qPCR data analysis and error-free result generation.

Apps and channels of Finbiosoft

its YouTube channel Finbiosoft—a BYG4lab Company has 9 subscribers and 6 videos.

Finbiosoft—a BYG4lab Company
YouTube 9 subscribers 6 videos Autos & Vehicles
Open channel

Videos from Finbiosoft

The most watched videos on Finbiosoft's YouTube channel, Finbiosoft—a BYG4lab Company (9 subscribers). Click a video to play it here.

Discover a new way to verify new instruments and tests
274 views
A quick tour of Results Manager
261 views
Precision (ANOVA) and Instrument comparison studies
207 views
Diagnostic accuracy study
141 views

More on Finbiosoft—a BYG4lab Company.

Funding Insights of Finbiosoft

  • Total Rounds 2
  • First Round $56,000

    (May 2015)

  • Investors Count 2

All 2 funding rounds of Finbiosoft with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2018Seed––
May 2015$56,000Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Finbiosoft

Finbiosoft has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, BYG4lab and Springvest.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Springvest is recognized as a leading growth investment service in Finland.
2012springvest.fiHelsinki, Finland
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Data management services are provided to laboratories.
1982byg4lab.comL Union, France
Premium access

Investor details for Finbiosoft

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Finbiosoft

3 people are tracked at Finbiosoft (3 in leadership).

NameRoleGroup
Teemu Qvick
Co-FounderLeadership
Jani Huttunen
Co-FounderLeadership
Akseli Virtanen
Co-Founder & CEOLeadership
Premium access

Complete people profiles for Finbiosoft

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Finbiosoft

4 dated milestones of Finbiosoft across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Finbiosoft is founded.
  2. Funding First funding round of $56K.
  3. Funding Latest funding round, Seed,.
  4. Exit Acquired by BYG4lab.

Web traffic of Finbiosoft

The website of Finbiosoft (finbiosoft.com) receives about 2.7K visits a month.

  • Monthly visits
    2.7K

    ▲ 8.6% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Finbiosoft

BYG4Lab’s Acquisition of Finbiosoft
Globallegalchronicle β€’ 2 years ago
Premium access

Complete news archive for Finbiosoft

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Finbiosoft

Finbiosoft was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Finbiosoft is headquartered in Espoo, Finland.

Akseli Virtanen is the CEO of Finbiosoft, as recorded in our data. They have also founded this company.

Cloud-based software for laboratory method and instrument verifications. The companys software suite includes Validation Manager, EQA Manager, and Results Manager for instrument and assay verifications and validations.

Finbiosoft offers Validation Manager, EQA Manager, and Results Manager.

Finbiosoft has 3 investors. Key investors include European Union, BYG4lab, and Springvest.

Finbiosoft operates through Finbiosoft Oy.

Yes. Finbiosoft was acquired by BYG4lab in March 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available